Yancheng Suhai Pharmaceutical Co., Ltd. was founded in 1990 and is currently located at Huafeng Industrial Park, Dafeng Port Economic Development Zone, Dafeng District, Yancheng City, Jiangsu Province.
For over 30 years since its establishment, adhering to the corporate spirit of "Unity, Pragmatism, Struggle and Innovation" and the business philosophy of "Integrity for Win-Win Cooperation", Suhai has realized the serialization of oxytetracycline derivative products, including Oxytetracycline Hydrochloride, Doxycycline Hyclate, Doxycycline Monohydrate, Doxycycline Sulfosalicylate and Metacycline Hydrochloride, with an annual production capacity of over 1,000 tons.
Among them, Doxycycline Hyclate and Doxycycline Monohydrate have obtained China GMP certification and EU COS certificates as well as Written confirmation for active substances exported to EU. Doxycycline Sulfosalicylate has successfully passed the quality audit of Pfizer Inc. and become an outstanding supplier to Pfizer. The company has passed on-site inspections by the U.S. FDA for three times in March 2015, April 2019 and April 2025 respectively.
Time flies in a fleeting moment as we look back on the past; challenges and opportunities coexist as we embrace the future. Suhai is willing to join hands with you to create a brilliant future together!